These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 22011439)
1. Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68. Ascierto ML; Worschech A; Yu Z; Adams S; Reinboth J; Chen NG; Pos Z; Roychoudhuri R; Di Pasquale G; Bedognetti D; Uccellini L; Rossano F; Ascierto PA; Stroncek DF; Restifo NP; Wang E; Szalay AA; Marincola FM BMC Cancer; 2011 Oct; 11():451. PubMed ID: 22011439 [TBL] [Abstract][Full Text] [Related]
2. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68. Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374 [TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68. Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320 [TBL] [Abstract][Full Text] [Related]
4. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68. Gentschev I; Donat U; Hofmann E; Weibel S; Adelfinger M; Raab V; Heisig M; Chen N; Yu YA; Stritzker J; Szalay AA J Biomed Biotechnol; 2010; 2010():489759. PubMed ID: 20379368 [TBL] [Abstract][Full Text] [Related]
5. Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus. Haddad D; Chen NG; Zhang Q; Chen CH; Yu YA; Gonzalez L; Carpenter SG; Carson J; Au J; Mittra A; Gonen M; Zanzonico PB; Fong Y; Szalay AA J Transl Med; 2011 Mar; 9():36. PubMed ID: 21453532 [TBL] [Abstract][Full Text] [Related]
6. Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates. Reinboth J; Ascierto ML; Chen NG; Zhang Q; Yu YA; Aguilar RJ; Carretero R; Worschech A; Zhao Y; Wang E; Marincola FM; Szalay AA Hum Gene Ther Methods; 2012 Oct; 23(5):285-96. PubMed ID: 23131031 [TBL] [Abstract][Full Text] [Related]
7. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice. Chen NG; Yu YA; Zhang Q; Szalay AA J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588 [TBL] [Abstract][Full Text] [Related]
8. Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma. Pugalenthi A; Mojica K; Ady JW; Johnsen C; Love D; Chen NG; Aguilar RJ; Szalay AA; Fong Y Cancer Gene Ther; 2015 Dec; 22(12):591-6. PubMed ID: 26584530 [TBL] [Abstract][Full Text] [Related]
9. Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells. Wang H; Chen NG; Minev BR; Szalay AA J Transl Med; 2012 Aug; 10():167. PubMed ID: 22901246 [TBL] [Abstract][Full Text] [Related]
10. Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68. Yu YA; Galanis C; Woo Y; Chen N; Zhang Q; Fong Y; Szalay AA Mol Cancer Ther; 2009 Jan; 8(1):141-51. PubMed ID: 19139123 [TBL] [Abstract][Full Text] [Related]
11. Vaccinia virus GLV-1h237 carrying a Walker A motif mutation of mouse Cdc6 protein enhances human breast tumor therapy in mouse xenografts. Hofmann E; Grummt F; Szalay AA Int J Oncol; 2011 Mar; 38(3):871-8. PubMed ID: 21249314 [TBL] [Abstract][Full Text] [Related]
12. Effective oncolytic vaccinia therapy for human sarcomas. He S; Li P; Chen CH; Bakst RL; Chernichenko N; Yu YA; Chen N; Szalay AA; Yu Z; Fong Y; Wong RJ J Surg Res; 2012 Jun; 175(2):e53-60. PubMed ID: 22341347 [TBL] [Abstract][Full Text] [Related]
13. Oncolytic immunotherapy using recombinant vaccinia virus GLV-1h68 kills sorafenib-resistant hepatocellular carcinoma efficiently. Ady JW; Heffner J; Mojica K; Johnsen C; Belin LJ; Love D; Chen CT; Pugalenthi A; Klein E; Chen NG; Yu YA; Szalay AA; Fong Y Surgery; 2014 Aug; 156(2):263-9. PubMed ID: 24957667 [TBL] [Abstract][Full Text] [Related]
14. Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter. Haddad D; Chen CH; Carlin S; Silberhumer G; Chen NG; Zhang Q; Longo V; Carpenter SG; Mittra A; Carson J; Au J; Gonen M; Zanzonico PB; Szalay AA; Fong Y PLoS One; 2012; 7(8):e41647. PubMed ID: 22912675 [TBL] [Abstract][Full Text] [Related]
15. Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling. Kyula JN; Khan AA; Mansfield D; Karapanagiotou EM; McLaughlin M; Roulstone V; Zaidi S; Pencavel T; Touchefeu Y; Seth R; Chen NG; Yu YA; Zhang Q; Melcher AA; Vile RG; Pandha HS; Ajaz M; Szalay AA; Harrington KJ Oncogene; 2014 Mar; 33(13):1700-12. PubMed ID: 23624923 [TBL] [Abstract][Full Text] [Related]
16. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers. Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815 [TBL] [Abstract][Full Text] [Related]
17. The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation. Zhang Q; Liang C; Yu YA; Chen N; Dandekar T; Szalay AA Mol Genet Genomics; 2009 Oct; 282(4):417-35. PubMed ID: 19701652 [TBL] [Abstract][Full Text] [Related]